Applications of Ethyl 4-(Butylamino)Benzoate in Industrial Manufacturing

Ethyl 4-(Butylamino)benzoate is a specialty intermediate valued for its unique aminobenzoate structure. As a manufacturer, we address the needs of multiple downstream industrial users who require this raw material for precise technical applications. The following segments represent established, compliant end-use sectors based on verified downstream demand and regulatory frameworks.

1. Local Anesthetic Synthesis for Pharmaceutical APIs

Ethyl 4-(Butylamino)benzoate functions as a targeted intermediate in the creation of local anesthetic pharmaceutical active ingredients, including butamben and its derivatives. Downstream pharmaceutical processors integrate this compound where a specific para-amino benzoate structure is required for esterification or amidation. The primary drivers for quality center around ICH, USP, and pharmacopoeial specifications. Downstream compliance with validated GMP ensures full traceability through the process, from raw intermediate to final injectable or topical anesthetics. Processers adjust charge ratios based on reaction yield and downstream impurity profile, requiring material with predictable assay and low isomer content to ensure safety for the end patient. Typical finished dosage forms include sterile ampoules for local anesthesia, compounded topical creams, and ointments intended for regulated clinical use.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• United States Pharmacopeia (USP) monographs
• European Pharmacopoeia (Ph. Eur.) standards
• 21 CFR 210/211 (US FDA cGMP for Finished Pharmaceuticals)

Typical usage ratio

• 5–20% molar basis in anesthetic intermediate synthesis, adjusted for targeted yield and downstream impurity profile
• Excess or limiting reagent status defined per batch based on final compound registration dossier specifications

Downstream process integration

• Charged in esterification or amidation step during API synthesis
• Controlled addition during reaction to manage byproduct and maintain batch reproducibility
• Integration monitored by in-process HPLC and end-point titration
• Intermediate purification before conversion to USP/Ph. Eur. compliant APIs

Final product types

• Injectable local anesthetic ampoules
• Medical topical anesthetic ointments and creams
• Sterile gels for dental or minor surgical anesthesia
• Compound pharmaceutical bulk for hospital pharmacy use

2. UV Absorber Component for Cosmetic Preparations

Downstream personal care and cosmetic formulators utilize Ethyl 4-(Butylamino)benzoate as a core intermediate in the synthesis of benign UVB absorber molecules, particularly in sunscreen innovation. It serves as a building block for alkylated para-amino benzoates that conform to cosmetic regulations regarding photostability and skin compatibility. Manufacturers rely on European Cosmetics Regulation (EC) No 1223/2009 and US FDA OTC monograph requirements when developing UV filters from this intermediate. Quality protocols demand traceability to GMP with full documentation of allergen and impurity-free status. Actual usage ratios depend on the UV-absorbing target molecule's required molar extinction and concentration in sunscreen product, thus requiring close coordination between upstream production and downstream blending processes. Finished products typically include regulated sun care emulsions and sprays marketed under both Europe and US personal care standards.

Industry compliance standards

• EU Cosmetics Regulation (EC) No 1223/2009
• US FDA OTC Monograph for Sunscreen Drug Products (21 CFR 352)
• ISO 22716 Cosmetics—Good Manufacturing Practices
• IFRA Standards (for non-sensitizing profiles)

Typical usage ratio

• Intermediate typically introduced at 15–35% mol/mol during UV absorber synthesis
• Final sunscreen formulations: downstream filtration and dosing according to SPF targets, generally 1–7% w/w UV filter in ready-to-market product

Downstream process integration

• Initial esterification or aminolysis to create target UVB absorber
• Integrated in reaction vessel with status monitored by UV-VIS and GC-MS analytical checks
• Post-reaction neutralization and crystallization before blending into cosmetic bases
• Assay-adjusted transfer to formulation lines for emulsion or spray products under ISO 22716 GMP

Final product types

• Certified sunscreens (SPF 15–50+)
• High-stability sun-care sprays and lotions
• Facial creams with integrated UVB/UVA-filter systems
• Marketed daily moisturizers with broad-spectrum protection labelling

3. Specialty Polymer Modifier for Performance Coatings

Engineered coatings formulators employ the compound as a functionalizing intermediate for acrylic and polyester resin technologies. The aminobenzoate core facilitates the creation of high-gloss, weather-durable, and flexible polymer backbones for technical coatings. Integration focuses on industrial needs for improved UV resistance and flexibility in automotive clearcoats, electronics encapsulation, and exterior architectural finishes. Downstream users reference REACH substance registration (Europe), specific ASTM coating standards, and ISO quality controls during procurement and formulation. Dosage and feed ratios vary by resin system, dictated by polymer chain length control and final mechanical testing, often ranging from 0.5% to 4% by weight. Downstream processes attach the intermediate via controlled polycondensation or solution co-polymerization. End products possess enhanced photostability for critical-use sectors.

Industry compliance standards

• REACH (EC) No 1907/2006 substance registration (EU)
• ISO 9001 Quality Management Systems for industrial coatings
• ASTM D3023, D6083, D2794 standards for weathering and impact resistance
• Automotive OEM technical approvals (for coating raw material content)

Typical usage ratio

• Generally 0.5–4% by weight, per polymer resin batch
• Ratio adjusted per achieved mechanical outcome and crosslink density in pilot runs

Downstream process integration

• Pre-polymer mixing with base acrylic or polyester resin stream
• Participation in chain extension or end-capping within main reactor
• Inline monitoring for molecular weight distribution via GPC
• Purification post-polymerization before blending with pigment or additive package

Final product types

• Automotive clearcoats (OEM-approved)
• Architectural high-gloss exterior coatings
• Electronics encapsulant resins for UV protection
• Marine and industrial protective topcoats

4. Intermediate for Agrochemical Synthesis

Specialty agrochemical producers use Ethyl 4-(Butylamino)benzoate as a precursor for the synthesis of active substances in herbicidal and growth regulation products. The chemical structure enables selective functionalization steps crucial for developing proprietary formulations, which must meet global MRL (Maximum Residue Level) and environmental safety obligations. Regulatory compliance attaches to FAO/WHO technical grade specifications and regionally enforced limits on impurities. Usage ratios depend on yield requirements and cis-trans selectivity for the target active. Integrators ensure controlled conversion and process monitoring, including downstream isomer separation and environmental safety evaluation. The final agrochemical products target high-value crop protection markets and comply with all pre-marketing authorization procedures globally.

Industry compliance standards

• FAO/WHO Specifications for Agricultural Pesticides
• Globally Harmonised System (GHS) for Safety and Labeling
• OECD Principles of Good Laboratory Practice (GLP)
• Maximum Residue Limit (MRL) by EPA, EFSA, and regional regulatory bodies

Typical usage ratio

• Usually 8–25% (molar) in precursor synthesis step, optimized for target molecule yield
• Ratio adjustments for active isomer selectivity and downstream environmental compliance

Downstream process integration

• Entry point as functionalizing amine or carboxylate in batch agrochemical synthesis
• Conversion followed by phase separation and rigorous impurity removal procedures
• Integration of final actives into powder or emulsion concentrate pre-blends
• QC testing for residue, persistence, and bioactivity before finished formulation packaging

Final product types

• Selectivity-enhanced herbicidal active substances
• Cereal, maize, and rice growth regulators
• Pre-formulated crop protection powder and liquid emulsions
• Seed treatment microgranules for regulated agricultural use